Sponsor
Tridem Bioscience FlexCo
Rudolf-Waisenhorn-Gasse 33a/2/3, 1230 Vienna, Austria
About the sponsor
The sponsor concentrates on therapeutic approaches for Parkinson's disease, emphasizing disease-modifying strategies and immune-based interventions.
- Disease-modifying vaccination
- Alpha-synuclein immunotherapy
- Neuroprotective agents
- Early-stage intervention
- Biomarker-driven trial design
Research efforts extend to novel immunogenic platforms and the assessment of therapeutic impact on motor function and disease progression.
Are you running a clinical trial?
Increase visibility for your trials and help patients find your site through our platform.